摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-丙基异噁唑-5-胺 | 747411-47-8

中文名称
3-丙基异噁唑-5-胺
中文别名
3-丙基-5-氨基异噁唑
英文名称
3-propylisoxazol-5-amine
英文别名
3-propyl-1,2-oxazol-5-amine
3-丙基异噁唑-5-胺化学式
CAS
747411-47-8
化学式
C6H10N2O
mdl
MFCD05270911
分子量
126.158
InChiKey
NORVABBMTGHGCF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    255.0±20.0 °C(Predicted)
  • 密度:
    1.077±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    9
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    52
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2934999090
  • 危险性防范说明:
    P261,P280,P305+P351+P338
  • 危险性描述:
    H302+H312+H332,H315,H319,H335

SDS

SDS:3cab3f27616943c6767c67de6739ff8a
查看

反应信息

  • 作为反应物:
    描述:
    3-丙基异噁唑-5-胺1-溴-3-苯基丙烷caesium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 16.0h, 以42%的产率得到N-(3-phenylpropyl)-3-propylisoxazol-5-amine
    参考文献:
    名称:
    Identification of diphenylalkylisoxazol-5-amine scaffold as novel activator of cardiac myosin
    摘要:
    To identify novel potent cardiac myosin activator, a series of diphenylalkylisoxazol-5-amine compounds 4-7 have been synthesized and evaluated for cardiac myosin ATPase activation. Among the 37 compounds, 4a (CMA at 10 µM = 81.6%), 4w (CMA at 10 µM = 71.2%) and 6b (CMA at 10 µM = 67.4%) showed potent cardiac myosin activation at a single concentration of 10 µM. These results suggested that the introduction of the amino-isoxazole ring as a bioisostere for urea group is acceptable for the cardiac myosin activation. Additional structure-activity relationship (SAR) studies were conducted. Para substitution (-Cl, -OCH3, -SO2N(CH3)2) to the phenyl rings or replacement of a phenyl ring with a heterocycle (pyridine, piperidine and tetrahydropyran) appeared to attenuate cardiac myosin activation at 10 µM. Additional hydrogen bonding acceptor next to the amino group of the isoxazoles did not enhance the activity. The potent isoxazole compounds showed selectivity for cardiac myosin activation over skeletal and smooth muscle myosin, and therefore these potent and selective isoxazole compounds could be considered as a new series of cardiac myosin ATPase activators for the treatment of systolic heart failure.
    DOI:
    10.1016/j.bmc.2020.115742
  • 作为产物:
    描述:
    3-氧代己腈盐酸羟胺 、 sodium hydroxide 作用下, 以 为溶剂, 以75%的产率得到3-丙基异噁唑-5-胺
    参考文献:
    名称:
    Identification of diphenylalkylisoxazol-5-amine scaffold as novel activator of cardiac myosin
    摘要:
    To identify novel potent cardiac myosin activator, a series of diphenylalkylisoxazol-5-amine compounds 4-7 have been synthesized and evaluated for cardiac myosin ATPase activation. Among the 37 compounds, 4a (CMA at 10 µM = 81.6%), 4w (CMA at 10 µM = 71.2%) and 6b (CMA at 10 µM = 67.4%) showed potent cardiac myosin activation at a single concentration of 10 µM. These results suggested that the introduction of the amino-isoxazole ring as a bioisostere for urea group is acceptable for the cardiac myosin activation. Additional structure-activity relationship (SAR) studies were conducted. Para substitution (-Cl, -OCH3, -SO2N(CH3)2) to the phenyl rings or replacement of a phenyl ring with a heterocycle (pyridine, piperidine and tetrahydropyran) appeared to attenuate cardiac myosin activation at 10 µM. Additional hydrogen bonding acceptor next to the amino group of the isoxazoles did not enhance the activity. The potent isoxazole compounds showed selectivity for cardiac myosin activation over skeletal and smooth muscle myosin, and therefore these potent and selective isoxazole compounds could be considered as a new series of cardiac myosin ATPase activators for the treatment of systolic heart failure.
    DOI:
    10.1016/j.bmc.2020.115742
点击查看最新优质反应信息

文献信息

  • Pyrrolidine Compounds Which Modulate The CB2 Receptor
    申请人:Berry Angela
    公开号:US20120142677A1
    公开(公告)日:2012-06-07
    Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain. (I)
    本发明揭示了调节CB2受体的化合物。本发明的化合物结合并激动CB2受体,并且可用于治疗炎症。那些是激动剂的化合物还可用于治疗疼痛。 (I)
  • Approach to the Library of Fused Pyridine-4-carboxylic Acids by Combes-Type Reaction of Acyl Pyruvates and Electron-Rich Amino Heterocycles
    作者:Dmitriy M. Volochnyuk、Sergey V. Ryabukhin、Andrey S. Plaskon、Yuri V. Dmytriv、Oleksandr O. Grygorenko、Pavel K. Mykhailiuk、Dmitriy G. Krotko、Alexei Pushechnikov、Andrey A. Tolmachev
    DOI:10.1021/cc100040q
    日期:2010.7.12
    A library of fused pyridine-4-carboxylic acids (including pyrazolo[3,4-b]pyridines, isoxazolo[5,4-b]pyridines, furo[2,3-b]pyridines, thieno[2,3-b]pyridines, and pyrido[2,3-d]pyrimidines) was generated by Combes-type reaction of acyl pyruvates and electron-rich amino heterocycles followed by hydrolysis of the ester. The library members were also demonstrated to undergo the standard combinatorial transformations including amide coupling and esterification, as well as less common heterocyclizations to 1,2,4-triazoles and 1,2,4-oxadiazoles.
  • PYRROLIDINE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR
    申请人:Boehringer Ingelheim International GmbH
    公开号:EP2384320B1
    公开(公告)日:2015-03-04
  • US8629157B2
    申请人:——
    公开号:US8629157B2
    公开(公告)日:2014-01-14
查看更多